Location-dependent B-cell function in glioblastoma

Ferdinando Pucci

doi:10.1158/2326-6066.CIR-19-0774

Location-dependent B-cell function in glioblastoma

Ferdinando Pucci

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Immunotherapy has shown remarkable successes in several tumor types and is now the first-line treatment for several conditions, including recurring disease. Nonetheless, a large fraction of patients does not respond, which is particularly true in glioblastoma. The results of Lee-Chang and colleagues point to intratumoral B cells as a potential target for immunotherapy.

Original language	English (US)
Pages (from-to)	1902
Number of pages	1
Journal	Cancer Immunology Research
Volume	7
Issue number	12
DOIs	https://doi.org/10.1158/2326-6066.CIR-19-0774
State	Published - 2019

ASJC Scopus subject areas

Immunology
Cancer Research

Access to Document

10.1158/2326-6066.CIR-19-0774

Cite this

@article{6df2287e57264007b20570ef6b0eb078,

title = "Location-dependent B-cell function in glioblastoma",

abstract = "Immunotherapy has shown remarkable successes in several tumor types and is now the first-line treatment for several conditions, including recurring disease. Nonetheless, a large fraction of patients does not respond, which is particularly true in glioblastoma. The results of Lee-Chang and colleagues point to intratumoral B cells as a potential target for immunotherapy.",

author = "Ferdinando Pucci",

note = "Publisher Copyright: {\textcopyright} 2019 American Association for Cancer Research.",

year = "2019",

doi = "10.1158/2326-6066.CIR-19-0774",

language = "English (US)",

volume = "7",

pages = "1902",

journal = "Cancer Immunology Research",

issn = "2326-6066",

publisher = "American Association for Cancer Research Inc.",

number = "12",

}

TY - JOUR

T1 - Location-dependent B-cell function in glioblastoma

AU - Pucci, Ferdinando

PY - 2019

Y1 - 2019

N2 - Immunotherapy has shown remarkable successes in several tumor types and is now the first-line treatment for several conditions, including recurring disease. Nonetheless, a large fraction of patients does not respond, which is particularly true in glioblastoma. The results of Lee-Chang and colleagues point to intratumoral B cells as a potential target for immunotherapy.

AB - Immunotherapy has shown remarkable successes in several tumor types and is now the first-line treatment for several conditions, including recurring disease. Nonetheless, a large fraction of patients does not respond, which is particularly true in glioblastoma. The results of Lee-Chang and colleagues point to intratumoral B cells as a potential target for immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=85076049531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076049531&partnerID=8YFLogxK

U2 - 10.1158/2326-6066.CIR-19-0774

DO - 10.1158/2326-6066.CIR-19-0774

M3 - Article

C2 - 31792003

AN - SCOPUS:85076049531

SN - 2326-6066

VL - 7

SP - 1902

JO - Cancer Immunology Research

JF - Cancer Immunology Research

IS - 12

ER -

Location-dependent B-cell function in glioblastoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this